Results 281 to 290 of about 71,423 (312)

The Role of Peritoneal Fibrosis in Encapsulating Peritoneal Sclerosis

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2005
Encapsulating peritoneal sclerosis (EPS) is a serious complication of long-term continuous peritoneal dialysis therapy. The progression of EPS has been classified into four stages by Kawanishi and colleagues: pre-EPS, and the inflammatory, encapsulating, and ileus stages.
Masanobu, Miyazaki, Yukio, Yuzawa
openaire   +2 more sources

MicroRNA expression profiling in peritoneal fibrosis

Translational Research, 2016
Peritoneal fibrosis (PF) is an intractable complication leading to peritoneal membrane failure in peritoneal dialysis (PD). The aim of this study was to identify microRNAs (miRNAs) involved in PF. Peritoneal tissue from a PF rat model was screened for miRNA expression using microarray analysis.
Yoshiyuki, Morishita, Hiromichi, Yoshizawa, Minami, Watanabe, Reika, Imai, Toshimi, Imai, Ichiro, Hirahara, Tetsu, Akimoto, Susumu, Ookawara, Shigeaki, Muto, Daisuke, Nagata   +9 more
openaire   +2 more sources

Eosinophilic Inflammation in Peritoneal Fibrosis Patients Undergoing Peritoneal Dialysis

2018
Renal replacement therapy is vital for patients with chronic renal failure. Each type of renal replacement therapy has its own characteristics, and patients select it according on their living environment or conception of quality of life. Under the recent medical environment in Japan, economic burden of dialysis is another concern.
Takehito, Kobayashi, Toru, Noguchi, Kohei, Saito, Fumitaka, Shirasaki, Hirohito, Kita, Makoto, Nagata, Hirokazu, Okada, Hidetomo, Nakamoto   +7 more
openaire   +2 more sources

Mechanisms and interventions in peritoneal fibrosis

Clinical and Experimental Nephrology, 2011
Peritoneal dialysis (PD) is an attractive treatment for patients with end-stage kidney disease (ESKD). However, long-term peritoneal dialysis is associated with development of functional and structural alterations of the peritoneal membrane. Several factors are implicated in the development of peritoneal fibrosis in PD patients. Inflammatory cytokines,
openaire   +2 more sources

Meconium peritonitis, intraperitoneal calcifications and cystic fibrosis

Pediatric Radiology, 1982
Twelve cases of meconium peritonitis were retrospectively reviewed in this study. Five of these patients had cystic fibrosis. Of the patients with cystic fibrosis, intraperitoneal calcifications were present in three (60%) and two (40%) had none. All seven patients (100%) who had meconium peritonitis without cystic fibrosis had abdominal calcifications.
L I, Finkel, T L, Slovis
openaire   +2 more sources

In Vitro Study of Peritoneal Fibrosis

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2007
Peritoneal fibrosis (PF) is an important issue in peritoneal dialysis (PD) because it remains one of the leading causes of patient drop-out from PD. In this review, we focus on in vitro approaches to the pathogenesis and therapeutic potential of PF and on associated clinical implications.
Kuan-Yu, Hung, Kuan-Dun, Wu, Tun-Jun, Tsai   +2 more
openaire   +2 more sources

Decorin ameliorates peritoneal fibrosis in peritoneal dialysis related peritonitis

2015
BACKGROUND: Peritonitis is a leading cause of peritoneal membrane failure in patients on peritoneal dialysis (PD). Decorin is a dermatan sulfate proteoglycan that possesses anti-fibrotic properties. Its role in peritoneal fibrosis remains to be fully defined.
Zhang, Q, Yung, S, Jiang, N, Chau, MKM, Chan, DTM   +4 more
openaire   +1 more source

FG4592 Ameliorates Peritoneal Dialysis-Associated Peritoneal Fibrosis

Journal of the American Society of Nephrology, 2023
Qimei Luo, Xianrui Dou
openaire   +1 more source

Peritoneal dialysis complicated by fungal peritonitis and peritoneal fibrosis

The American Journal of Medicine, 1984
Edward S. Eisenberg, Ruy Soeiro
openaire   +2 more sources

Peritoneal Flap Ureteropexy for Idiopathic Retroperitoneal Fibrosis

Journal of Urology, 1987
Summary— Eight patients had 13 ureters treated by peritoneal flap ureteropexy. There were no significant post‐operative complications. Eleven ureters were functioning normally after an average follow‐up of 28 months. The operation is suggested as a method of choice where omental wrapping is not possible.
openaire   +2 more sources